Angela Christine Argento, MD, weighs the relative benefits of formal education and practical experience in the development of personalized treatment for advanced non–small cell lung cancer.
Recalling positive experiences with various mentors, Dr Argento implores clinicians to talk to and listen to patients in order to understand their priorities and what they are hoping to gain from treatment. Doing so will provide the necessary framework for complete and optimal treatment.
Medscape © 2022 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Advanced and Metastatic NSCLC: Lessons From Patients Beyond the Classroom - Medscape - Sep 29, 2022.